EPA names BD, Edwards and Medtronic on list of higher-risk sterilization facilities - MedTech Dive
EPA has identified BD, Edwards, and Medtronic as higher-risk sterilization facilities, which may lead to increased scrutiny and regulatory requirements.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. BD, Edwards, and Medtronic, along with other sterilization facilities that may be affected by increased regulatory oversight. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
These companies are now classified as higher-risk, potentially leading to more stringent compliance requirements and inspections.
Who it affects
BD, Edwards, and Medtronic, along with other sterilization facilities that may be affected by increased regulatory oversight.
What you must do
Review and enhance compliance protocols to meet potential new regulations and prepare for increased inspections.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Supreme Court Rejection of Trump Tariffs Has Nuanced Implications for Pharma Importers - pharmtech.com
- Imaging manufacturer Guerbet faces financial challenges following recent FDA warning - Radiology Business
- Sandoval signs diabetes drug transparency, rooftop solar bills into law on Southern Nevada swing - thenevadaindependent.com
- Montana Now Licenses Clinics to Sell Treatments the FDA Has Not Approved, and the Rules Are Live - medicaldaily.com
- The Impact of Reclassifying 7-OH Products - pharmtech.com